Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-011468
Filing Date
2016-07-20
Accepted
2016-07-20 16:29:31
Documents
27
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mixx_10q.htm 10-Q 212093
2 CERTIFICATION mixx_ex3101.htm EX-31.01 7472
3 CERTIFICATION mixx_ex3102.htm EX-31.02 7164
4 CERTIFICATION mixx_ex3201.htm EX-32.01 3607
5 CERTIFICATION mixx_ex3202.htm EX-32.02 3688
12 img001.jpg GRAPHIC 16223
13 img002.jpg GRAPHIC 11076
14 img003.jpg GRAPHIC 20870
15 img004.jpg GRAPHIC 13130
  Complete submission text file 0001477932-16-011468.txt   905754

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mixx-20160531.xml EX-101.INS 41746
7 XBRL TAXONOMY EXTENSION SCHEMA mixx-20160531.xsd EX-101.SCH 10346
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mixx-20160531_cal.xml EX-101.CAL 37092
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mixx-20160531_def.xml EX-101.DEF 4167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mixx-20160531_lab.xml EX-101.LAB 95268
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mixx-20160531_pre.xml EX-101.PRE 61962
Mailing Address 16000 N. 80TH STREET SUITE E SCOTTSDALE AZ 85260
Business Address 16000 N. 80TH STREET SUITE E SCOTTSDALE AZ 85260 480-371-1100
MIX 1 LIFE, INC. (Filer) CIK: 0001501112 (see all company filings)

EIN.: 680678499 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-55422 | Film No.: 161775729
SIC: 2834 Pharmaceutical Preparations